Praxis Precision Medicines, Inc. PRAX Common stock, capital shares reserved for future issuance
Common stock, capital shares reserved for future issuance at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s common stock, capital shares reserved for future issuance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s common stock, capital shares reserved for future issuance?
- Praxis Precision Medicines, Inc. (PRAX) reported common stock, capital shares reserved for future issuance of $6.73M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s common stock, capital shares reserved for future issuance changed year-over-year?
- Praxis Precision Medicines, Inc.'s common stock, capital shares reserved for future issuance increased by 27.3% year-over-year, from $5.28M to $6.73M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s common stock, capital shares reserved for future issuance?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s common stock, capital shares reserved for future issuance has grown at a -10.6% compound annual growth rate (CAGR), from $9.31M to $5.32M.